inhibitors. Thus, proteinase inhibitors become more The human hemofiltrate peptide HF6478, a putative and more important as drugs against currently untreatserine proteinase inhibitor, which is part of the precur-able diseases. The most prominent example for this sor protein LEKTI, was cloned, overexpressed, and kind of therapy is probably the rationally designed HIVpurified. HF6478 contains two disulfide bridges with 1 2 proteinase inhibitors (2), although the observed num-1-4, 2-3 connectivity, sharing partial homology to Kazal-bers of resistances against several of these drugs are type domains and other serine proteinase inhibitors. increasing (3).
It was expressed as thioredoxin (Trx) fusion protein,
HF6478 (hemofiltrate peptide with molecular weight and disulfide formation occurred in the oxidative cyto-6478 Da) seems to be a serine proteinase inhibitor acplasm of Escherichia coli Origami (DE3) strain which cording to sequence homologies with other inhibitors.
carries a trxB

؊
/gor522
؊ double mutation. The soluble It is isolated from human blood and is part of the precurfusion protein was purified using metal-chelating sor protein LEKTI that exhibits 15 potential inhibitory affinity chromatography. Cleavage of the Trx fusion domains (4) . The amounts of HF6478 (55 amino acids) protein with factor Xa and subsequent purification isolated from human blood were sufficient for amino yielded the final product in amounts sufficient for acid sequencing and mass spectrometry (4) . Further structural studies. Characterization of recombinant studies like inhibition assays and the determination of HF6478 was done by amino acid sequencing, mass specthe three-dimensional protein structure require higher trometry, capillary zone electrophoresis, and CD specamounts of HF6478, making expression of the recombi- purification yields rHF6478 in amounts sufficient for with buffer A and 50 mM Tris/HCl, pH 8.0, 300 mM NaCl, 30 mM imidazole, and the absorbed proteins were NMR spectroscopy. The recombinant protein has been analyzed by mass spectrometry, CZE, and circular di-eluted with 50 mM Tris/HCl, pH 8.0, 300 mM NaCl, 200 mM imidazole. The fractions containing the fusion chroism (CD) spectroscopy. The disulfide connectivity of rHF6478 was determined by CZE, using a chemically protein (as verified by SDS-PAGE) were dialyzed against 50 mM Tris/HCl, pH 8.0, 100 mM NaCl to resynthesized version of the peptide with known disulfide pattern as reference.
duce the high imidazole concentrations. The protein concentration was estimated using the BCA assay (Pierce) (8) .
MATERIALS AND METHODS
To remove the Trx-tag, the dialyzed protein solution Construction of the Expression Vector pET-32a-Xawas adjusted to a final concentration of 5 mM CaCl 2 hf6478
and incubated at room temperature with factor Xa (Novagen; 1 unit/mg of Trx-Xa-HF6478) for 16 h. After A fragment of the LEKTI cDNA encoding the peptide stopping digestion by addition of 1 mM PMSF the sam-HF6478 was amplified by PCR (7) using a forward ple was loaded on a Ni 2+ -NTA column (3-ml bed vol), primer which introduces a KpnI site and a sequence preequilibrated in buffer A without imidazole. The colencoding a factor Xa cleavage site at the 5Ј end of the umn was washed with buffer A (without imidazole) and gene (GGA GGA GGA TCC GGT ACC ATC GAA GGT the rHF6478 containing fractions were pooled and dia-CGT AAG AAT GAA GAT CAG GAA ATG). The reverse lyzed against buffer B (20 mM ammonium acetate, pH primer contains a XhoI site at its 5Ј end (GGA GGA 6.0). After lyophylization the protein was solubilized in CTC GAG TTA CTG TGA TTT TGC TTC TTT TTC 1-2 ml distilled water and the concentrated protein CAG). The fragment was inserted into the T7 RNA solution (4-5 mg/ml) was loaded on a Superdex 75 HR polymerase-based expression vector pET-32a (Nova-30/10 column (Pharmacia Biotech; at a flow rate of 0.15 gen). The resulting pET-32a-Xa-hf6478 is able to proml/min), preequilibrated in buffer B. The rHF6478 conduce the peptide HF6478 with an NH 2 -terminal E. coli taining fractions were pooled and dialyzed against disthioredoxin fusion (Trx-tag, Novagen). The two proteins tilled water, and the protein concentration was estiare connected by a 43-amino-acid linker containing six mated. The lyophylized protein was used for further histidine residues and a factor Xa cleavage site recharacterization by amino acid sequencing, mass specsulting in the fusion protein Trx-Xa-HF6478.
trometry, CZE, and CD spectroscopy.
Preparation of Soluble Extracts
Characterization of Recombinant HF6478 A starter culture of 50 ml LB containing 200 g/ml Electrospray mass spectra were recorded on a biomoampicillin, 15 g/ml kanamycin, and 12.5 g/ml tetra-lecular mass analyzer (Perkin Elmer, Sciex API 100), cycline was inoculated with the E. coli strain Origami using a protein sample solubilized in 100 l of 50% (DE3)/pET-32a-Xa-hf6478 and grown overnight at CH 3 CN and 0.2% HCOOH. 37ЊC. The starter culture was used to inoculate 1 liter Capillary zone electrophoresis was carried out on a of LB medium (containing 200 g/ml ampicillin, 15 g/ Bio-Rad CZE CE3000 system (Bio-Rad, Munich, Germl kanamycin, and 12.5 g/ml tetracycline) at an OD 600 many) in 0.1 M phosphate buffer with polymer modifier of 0.1. Cultures were grown to an OD 600 of 0.8, and the (pH 2.5) (capillary, 30 cm ϫ 50 m (uncoated); temperaexpression of the recombinant protein was induced by ture, 292K; absorbance was detected at 200 nm; run addition of IPTG to 1 mM. After 3 h, cells were har-time, 20 min). vested and resuspended in 20 ml of buffer A (50 mM Tris/HCl, pH 8.0, 300 mM NaCl, 10 mM imidazole) with RESULTS AND DISCUSSION 0.5 mM PMSF, 0.2 mg/ml lysozyme, 0.2 mg/ml DNaseI, and 2 mg/ml benzamidine. The cells were lysed by three Purification of Recombinant HF6478 30-s sonication steps (T ϭ 4ЊC; Labsonic U sonicator
The gene fragment coding for the peptide HF6478 at 150 W intensity) followed by overnight freezing at was combined with a sequence encoding a factor Xa Ϫ80ЊC. After thawing, the extract was clarified by cencleavage site at its 5Ј end, using standard PCR techtrifugation for 60 min at 40,000 rpm, at 4ЊC in a TFT niques (7) and was cloned into pET-32a. As host strain 70.38 rotor.
for the expression of recombinant HF6478, E. coli Origami (DE3) (Novagen), a trxB Ϫ /gor522 Ϫ double mutant Purification of Recombinant HF6478 was used, allowing disulfide formation in the oxidative cytoplasm of this strain (5, 6). Thus, recombinant The soluble extract (20 ml) was loaded on a Ni 2+ -NTA column (3-ml bed vol, Qiagen, batch column) which was HF6478 with an NH 2 -terminal E. coli thioredoxin fusion was expressed by the strain E. coli Origami (DE3)/ preequilibrated in buffer A. The column was washed pET-32a-Xa-hf6478. Expression of the Trx fusion pro-factor Xa cleavage site and Arg 74 as part of the thioredoxin sequence, as well as arginines 129 and 143, lotein (Trx-Xa-HF6478; 212 amino acids; 23.4 kDa) was induced by 1 mM IPTG with an expression level of 40% cated between His-tag and factor Xa cleavage site, as potential secondary cleavage sites. As the sequence of of total cellular proteins (Fig.1a, lane 2) as deduced by densitometric analysis of Coomassie-stained SDS-HF6478 does not contain any arginine residues, the overall yield of the peptide would not have been influ-PAGE (data not shown). To avoid reduction of disulfide bridges and renaturation of denatured fusion protein enced by an unspecific activity of factor Xa. After incubation with the enzyme, a strong decrease in intensity from inclusion bodies, only the soluble fraction of cell lysate was used for further purification, containing fu-of the fusion protein band (Fig. 1a, lane 5) was observed, showing that cleavage of Trx-Xa-HF6478 was possible. sion protein at 28% of the soluble fraction (Fig. 1a,  lane 3) . Trx-Xa-HF6478 was purified by one-step Ni 2+ -In addition to the expected bands of apparently 17 kDa (Trx-tag) and 7 kDa (rHF6478) (Fig. 1a, lane 5 , marked chelating affinity chromatography (9) with a purity of 66% (Fig. 1a, lane 4) . A total of 27 mg of recombinant by arrow), two bands with apparent molecular masses of 15 and 14 kDa (Fig. 1a, lane 5) were obtained, indicatTrx fusion protein was obtained from 2.4 g wet wt cells (1 liter of culture).
ing that secondary cleavage has indeed occurred after Arg 129 and Arg 143. Size-exclusion chromatography Enterokinase (EK) and factor Xa are, according to their specificity (EK, DDDDK↓; factor Xa, IEGR↓), the (SEC) to remove secondary cleavage products resulted in substantial loss of rHF6478 (data not shown), necesonly commercially available proteinases that cleave the fusion protein to rHF6478 without additional amino sitating a different purification strategy. As part of all larger peptide fragments (comprising amino acids 1-acids at its NH 2 -terminus. Since we were unable to cleave the thioredoxin domain from a fusion protein 129, 1-143, and 1-157), the His-tag allowed a second Ni 2+ -chelating affinity chromatography step to purify containing the EK cleavage site, as in the original pET32a vector construct, a modified Trx fusion protein con-rHF6478 from secondary cleavage products (Fig. 1, lane  6) . After SEC to remove small cleavage fragments (comtaining a factor Xa cleavage site was used. Compared to the EK cleavage site, sequences similar to that recog-prising amino acids 129-143, 129-157, and 143-157; Fig. 1b) , rHF6478 with apparent homogeneity was obnized by factor Xa are more prevalent, leading to a higher probability of secondary cleavage (10, 11). The tained (Fig. 2b) . Starting with 27 mg of Trx fusion protein containing 7.4 mg of rHF6478, the total of 3 to 3.6 fusion protein (Trx-Xa-HF6478) contains Arg 157 of the rHF6478 was estimated to be 7 kDa, in agreement with the molecular weight obtained by electrospray mass spectrometry (6477.69 Ϯ 0.68 Da) as well as with the calculated value of 6477.59 Da.
When expression of His-tagged HF6478 was carried out in E. coli BL21 (DE3), all of the three possible disulfide isomers were formed, making isolation of the correct isoform necessary. In contrast, expression of rHF6478 as Trx fusion protein in E. coli Origami (DE3) resulted in a uniform product. In order to determine its disulfide pattern we took advantage of the significantly different retention times of the three possible disulfide isomers in RP-HPLC (data not shown) and CZE. Coinjection (Fig. 2c ) of rHF6478 with a synthetic version of the peptide with selectively synthesized disulfides (Fig.  2a) resulted in a strong single peak, indicating a consistent 1-4, 2-3 (Cys 8-Cys 44; Cys 22-Cys 41) connectivity for both peptides suggested to be the native form in human blood filtrate.
The CD spectrum of rHF6478 from 185 to 250 nm (Fig. 3 ) is typical for a protein containing both ␣-helix and ␤-sheet with a broad minimum between 208 and 222 nm as well as an intense positive band at 195 nm. Evaluation of the spectrum resulted in an estimate of 19.8% ␣-helix and 33.2% ␤-sheet (12). As HF6478 contains two disulfide bridges, as well as the side chains of aromatic amino acid residues that influence CD spectra (13), the exact contents of regular secondary structural elements of the peptide will be known only after determination of the detailed 3D structure.
CONCLUSIONS
When extracellular proteins are expressed in conventional E. coli strains, missing or wrong disulfide bridges mg of recombinant HF6478 obtained after cleavage and subsequent purification corresponds to an overall recovery yield of 40 to 48%. Isotopic labeling, as required for heteronuclear NMR experiments, can be performed in minimal medium, leading to similar overall recovery yields. HF6478   FIG. 3 . The CD spectrum of rHF6478 is typical for a protein conThe NH 2 -terminal sequence of rHF6478 taining both ␣-helix and ␤-sheet. The spectrum was recorded on a (KNEDQEMCH-) was verified by sequencing. Using Jasco J-810 spectrometer at room temperature with 30 M rHF6478 in H 2 O, pH 4.5.
Characterization of Recombinant
SDS-PAGE, the apparent molecular weight of
